Compliance Architects offers expert GxP consulting for pharmaceutical, medical device, and biotech industries, specializing in FDA compliance, QMSR transition, and inspection readiness.
Compliance Architects provides comprehensive GxP quality, regulatory, and compliance consulting services tailored for the pharmaceutical, medical device, and biotech sectors. They specialize in guiding companies through complex regulatory landscapes, including the transition to QMSR (ISO 134485 integration), FDA inspection readiness, and quality system redevelopment. With deep expertise in FDA regulations and quality management systems, Compliance Architects helps organizations plan, implement, maintain, and monitor their compliance efforts. Their services include gap analysis, documentation overhaul, training, risk management, and strategic planning to ensure adherence to current and evolving regulatory expectations. They focus on transforming quality systems into a competitive advantage, driving efficiency, and mitigating compliance risks. Their team of seasoned professionals is adept at addressing FDA 483 citations and Warning Letters, offering swift and decisive action to safeguard businesses. Compliance Architects is a trusted partner for life science companies aiming to achieve and maintain the highest standards of quality and regulatory compliance in a dynamic global market.
About
**Who they are** Compliance Architects is a GxP consulting firm specializing in FDA compliance for the pharmaceutical, medical device, and biotech industries.
**Expertise & scope** * Expert GxP consulting * FDA compliance and regulatory consulting * QMSR transition and inspection readiness * Quality system improvement and redevelopment * Mock FDA inspections and readiness training * Data integrity assessments and remediation * Support for FDA 483 and Warning Letter citations * Pre-Approval Inspection (PAI) readiness for product commercialization * Services cover Pharmaceuticals, Medical Devices and Diagnostics, Biopharmaceuticals, and Combination Products.
**Reputation / proof points** * Experienced quality professionals with deep FDA and industry experience. * Team includes ex-FDA Investigators for mock inspections.
Additional information
Compliance Architects emphasizes proactive preparation for FDA inspections, viewing quality systems as a competitive advantage. They offer a comprehensive approach to inspection readiness, including mock inspections conducted by former FDA investigators, specialized training programs, and hands-on coaching. Their services aim to help organizations identify and address compliance gaps, mitigate risks, and respond effectively to regulatory citations, ultimately ensuring uninterrupted product supply and successful commercialization.
Key Highlights
Specializes in GxP consulting for pharmaceutical, medical device, and biotech industries.
Source
“Compliance Architects offers expert GxP consulting for pharmaceutical, medical device, and biotech industries, specializing in FDA compliance, QMSR transition, and inspection readiness.”
Offers mock FDA inspections conducted by former FDA Investigators.
Source
“At Compliance Architects®, we understand the importance of being inspection-ready at all times. That’s why we offer comprehensive mock FDA inspections, designed to simulate real FDA interactions and prepare your organization for regulatory scrutiny.”
Provides comprehensive inspection readiness training, including a 90-minute online program.
Source
“Our 90-minute online inspection readiness training program, Survive and Thrive During FDA Inspections, provides you with a comprehensive background in FDA’s inspection authority...”
Assists with addressing FDA 483 or Warning Letter citations effectively.
Source
“Compliance Architects is the trusted partner you need to assess, address, and resolve FDA 483 or Warning Letter citations effectively.”
Guides companies through Pre-Approval Inspection (PAI) readiness for product commercialization.
Source
“Compliance Architects specializes in guiding companies through the complexities of the PAI readiness process, helping them secure FDA approval efficiently and confidently.”
Companies seeking to improve or redevelop their quality systems.
Organizations preparing for FDA inspections or responding to citations.
Life science companies needing to ensure GxP compliance.
How engagement typically works
Consultative approach tailored to unique business and operational needs.
Hands-on coaching and training for internal teams.
Expert-led assessments and remediation planning.
Typical deliverables
Quality System Redevelopment Plans
Mock FDA Inspection Reports
Inspection Readiness Training Materials
Corrective Action Plans for FDA Citations
PAI Readiness Strategies
Good to know
Best when organizations are proactive about compliance and inspection readiness.
Most effective for companies in the pharmaceutical, medical device, and biotech sectors.
HQ: United States, USA
Languages: English
Timezones: EST, PST
Status: listed
Services & Capabilities
FDA QMSR Transition & Inspection Readiness (ISO 13485 Alignment)
Jurisdictions: US
Countries: US
Industries: Medical Devices, IVD
Onboarding time: 7–21 days
Pricing model: Custom pricing
Service Types: QMSR/ISO 13485 Gap Assessment, SOP / Documentation Remediation, Mock FDA Inspection, Training & Competency Programs, 483 Response & Remediation Support
Earliest Start: flexible
Delivery Mode: Hybrid
Inspection Experience: Former FDA investigator on team, Supports mock inspections regularly, ISO 13485 lead auditor capability